{
    "2018-02-23": [
        [
            {
                "time": "2023-10-05",
                "original_text": "Pharma Stock Roundup: AZN's Imfinzi Gets 2nd FDA Nod, MRK to Buy Australian Firm",
                "features": {
                    "keywords": [
                        "AZN",
                        "Imfinzi",
                        "FDA",
                        "MRK",
                        "Australian Firm"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Todayâ€™s Biotech Movers: Sangamo Therapeutics, Inc. (NASDAQ:SGMO) And Novo Nordisk A/S (ADR) (NYSE:NVO)",
                "features": {
                    "keywords": [
                        "Sangamo Therapeutics",
                        "Novo Nordisk",
                        "Biotech Movers"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology",
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}